Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...
Individual-level attribution modeling reveals that real-world semaglutide effectiveness is not a fixed property of the molecule, but an interaction between pharmacological exposure and modifiable care ...
US$46 million investment to establish wholly owned Puerto Rico subsidiary supporting U.S. manufacturing, supply security, and long-term growth of BESREMi (R) (ropeginterferon alfa-2b) Company plans to ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2025 Earnings Call Transcript February 11, 2026 Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-0.
Hypertension is the leading risk factor for cardiovascular disease, the most common cause of death worldwide. Less than half the people with high blood pressure are aware of their diagnosis, and only ...
Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel fear of an exam for a treatable cancer.
Testimony in the Tara Baker murder trial picked back up in an Athens courtroom Wednesday, with a Georgia Bureau of ...
The daily podcast round-up is just one way the Times is adopting in-house AI transcription and summarization tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results